PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 126 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $174,000 | +54.0% | 18,979 | +62.8% | 0.02% | +30.8% |
| Q1 2021 | $113,000 | -21.0% | 11,657 | -17.5% | 0.01% | -43.5% |
| Q3 2020 | $143,000 | -49.8% | 14,124 | -58.1% | 0.02% | -58.9% |
| Q1 2020 | $285,000 | +9.2% | 33,731 | +13.0% | 0.06% | +33.3% |
| Q4 2019 | $261,000 | +4.4% | 29,844 | +28.5% | 0.04% | -4.5% |
| Q3 2019 | $250,000 | -27.7% | 23,217 | +160.3% | 0.04% | -22.8% |
| Q1 2019 | $346,000 | +10.2% | 8,921 | -42.2% | 0.06% | +5.6% |
| Q4 2018 | $314,000 | +33.6% | 15,430 | +340.9% | 0.05% | -14.3% |
| Q3 2016 | $235,000 | – | 3,500 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |